刘靖. 从2018年欧洲高血压指南及新近临床研究谈β-受体阻滞剂在高血压中的应用[J]. 中国全科医学, 2019, 22(15): 1763-1765. DOI: 10.12114/j.issn.1007-9572.2019.00.061.
LIU Jing. Application of Beta Blockers in Hypertension:Insights from European Hypertension Guideline 2018 and Recent Clinical Studies [J]. Chinese General Practice, 2019, 22(15): 1763-1765. DOI: 10.12114/j.issn.1007-9572.2019.00.061.
[1]WILLIAMS B,MANCIA G,SPIERING W,et al.2018 ESC/ESH guidelines for management of arterial hypertension[J].Eur Heart J,2018,39(33):3021-3104.DOI:10.1093/eurheartj/ehy339.
[2]WHELTON P K,CAREY R M,ARONOW W S,et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention,detection,evaluation,and management of high blood pressure in adults:executive summary:a report of the ACC/AHA task force on clinical practice guidelines[J].J Am Coll Cardiol,2018,71(19):2199-2269.DOI:10.1016/j.jacc.2017.11.005.
[3]LINDHOLM L H,IBSEN H,DAHL?F B,et al.Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study(LIFE):a randomised trial against atenolol[J].Lancet,2002,359(9311):1004-1010.DOI:10.1016/S0140-6736(02)08090-X.
[4]National Institute for Health and Clinical Excellence.Management of hypertension in adults in primary care(clinical guideline 34.)2006[EB/OL].[2018-12-10].http://www.nice.org.uk/CG034.
[5]LAW M R,MORRIS J K,WALD N J.Use of blood pressure lowering drugs in the prevention of cardiovascular disease:meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies[J].BMJ,2009,338:b1665.DOI:10.1136/bmj.b1665.
[6]SABIDó M,HOHENBERGER T,GRASSI G.Pharmacological intervention in hypertension using beta-blockers:real-world evidence for long-term effectiveness[J].Pharmacol Res,2018,130:191-197.DOI:10.1016/j.phrs.2018.01.010.
[7]HOLMAN R R,PAUL S K,BETHEL M A,et al.Long-term follow-up after tight control of blood pressure in type 2 diabetes[J].N Engl Med,2008,359(15):1565-1576.
[8]LIU J.Management of hypertension in young and middle-aged patient:unmet need[C]//European Meeting on Hypertension and Cardiovascular Protection.Milan:2017.
[9]NERENBERG K A,ZARNKE K B,LEUNG A A,et al.Hypertension Canada's 2018 Guidelines for Diagnosis,Risk Assessment,Prevention,and Treatment of Hypertension in Adults and Children[J].Can J Cardiol,2018,34(5):506-525.DOI:10.1016/j.cjca.2018.02.022.
[10]WANG Z,CHEN Z,ZHANG L,et al.Status of hypertension in China:results from the China hypertension survey,2012—2015[J].Circulation,2018,137(22):2344-2356.DOI:10.1161/CIRCULATIONAHA.117.032380.